Tetravalent influenza vaccine (Wuhan Institute of Biological Products)

四价流感病毒裂解疫苗（武汉生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTetravalent influenza vaccine (Wuhan Institute of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection

Global Approved IndicationsInfluenza, Human

Approved Indications in ChinaInfluenza, Human

Original Approved Country/TerritoryMainland China

Original Approved Date2020/02/25

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesWuhan Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsInfluenza A virus infectionsInfluenza B virus infection

Other Information

ATC CodeJ07BB02